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Abstract
Phaeobacter inhibens DSM 17395, a model organism for marine Roseobacter group, was
studied for its response to its own antimicrobial compound tropodithietic acid (TDA). TDA
biosynthesis is encoded on the largest extrachromosomal element of P. inhibens, the 262
kb plasmid, whose curation leads to an increased growth and biomass yield. In this study,
the plasmid-cured strain was compared to the wild-type strain and to transposon mutants
lacking single genes of the TDA biosynthesis. The data show that the growth inhibition of the
wild-type strain can be mainly attributed to the TDA produced by P. inhibens itself. Oxygen
uptake rates remained constant in all strains but the growth rate dropped in the wild-type
which supports the recently proposed mode of TDA action. Metabolome analysis showed
no metabolic alterations that could be attributed directly to TDA. Taken together, the growth
of P. inhibens is limited by its own antibacterial compound due to a partial destruction of the
proton gradient which leads to a higher energetic demand. The universal presence of TDA
biosynthesis in genome-sequenced isolates of the genus Phaeobacter shows that there
must be a high benefit of TDA for P. inhibens in its ecological niche despite the drawback on
its metabolism.
Introduction
Due to its nutritional versatility Phaeobacter inhibens DSM 17395, originally isolated from sea-
water at the Spanish Atlantic coast in Galicia [1, 2] is commonly used as a model system to
investigate the physiology and metabolic capabilities of marine bacteria living in nutrient-rich
environments [3–5]. In addition to its 3.2 Mb chromosome, P. inhibens DSM 17395 carries
three extrachromosomal elements of 65, 78 and 262 kb size, which were classified as chromids
based on a relatively synonymous codon usage [6, 7] but will be further on designated as “plas-
mids” for reasons of simplicity. The largest plasmid encodes, in addition to proteins involved
in metabolic pathways and exopolysaccharide formation, proteins involved in the formation of
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the antibacterial compound tropodithietic acid (TDA) [8–10]. In a recent study by Zhao et al.
(2016) [11], the probiotic effect of P. inhibens in aquacultures is attributed to TDA in killing
unwanted marine pathogens [12–14].
TDA is supposed to act by disturbing the proton gradient due to an exchange of extracellu-
lar protons for cytoplasmic cations [15]. Furthermore, Wilson et al. (2016) [15] proposed a
counteracting resistance mechanism consisting of an active proton export in P. inhibens via
the γ-glutamyl cycle. They claimed that three genes of P. inhibens DSM 17395 (tdaR1 to tdaR3)
are necessary for conferring an increased TDA tolerance (S2 File). However, experiments to
select TDA-resistant or -tolerant strains of Escherichia coli, Pseudomonas aeruginosa or Staphy-
lococcus aureus were not successful and furthermore, Salmonella typhimurium mutants with
nonfunctional efflux pump and porin genes showed the same TDA susceptibility as wild-type
strains [16]. Porsby et al. (2011) [16] explained an observed inhibition of the TDA-producing
Phaeobacter strain 24–7 by a low TDA concentration with the prediction that TDA-producing
strains express their resistance mechanism only during active TDA-production, which was not
active in their experimental setup. In process-controlled bioreactors, P. inhibens DSM 17395
showed a faster growth (3.2-fold higher growth rate), a ~40% higher growth yield and a signifi-
cant higher carbon usage efficiency when the 262 kb plasmid encoding the TDA biosynthesis
genes was missing [8]. The TDA biosynthetic gene cluster (S2 File) consists of 6 genes coding
for proteins involved in the biosynthesis, 1 transcriptional regulator and 3 genes which were
described as resistance genes by Wilson et al. (2016) [15]. The biosynthesis of TDA and cata-
lyzed steps are proposed by Brock et al. (2014) [10]. They proposed the biosynthesis to start
from phenyl-acetate. The TDA production is induced by N-3-hydroxydecanoylhomoserine
lactone (R-3OHC10-HSL) and also by TDA itself [9].
In this study, we cultivated different transposon mutants of genes that are essential for the
TDA biosynthesis and compared them to the 262 kb plasmid-cured mutant and the wild-type
of P. inhibens DSM 17395 to analyze the impact of endogenously produced TDA on P. inhibens
itself. The data clearly show that the absence of TDA is the major reason for the higher biomass
yield of mutant strains lacking a functional TDA biosynthesis. Furthermore, our analysis docu-
ments that with increasing TDA concentration the wild-type strain uses a higher share of oxy-
gen to keep up its proton gradient. Whereas the mutants deplete the whole of the available
sources the wild-type decreases its growth rate to 35% compared to ½ ODmax despite the fact
that substrate is still available. We could not detect any increase of respiratory activity as a
defensive counteraction against TDA on metabolic level.
Materials and methods
Strains and growth conditions
Strains used in this work are listed in Table 1. Transposon mutagenesis was performed and
mutants were checked for homogeneity as previously described [17] (S1 File).
All cultivations were performed in a defined salt water medium [18] with 1% of casamino
acids as carbon source. Casamino acids were obtained from Merck (Darmstadt, Germany),
prepared in a 5x stock solution and adjusted to pH 6.5 prior to sterile filtration. All cultivations
were conducted at 150 rpm and 28˚C in an orbital incubator (Certomat BS-1, orbit 50 mm;
Sartorius, Go¨ttingen, Germany). Growth was followed spectrophotometrically (OD600nm) and
gravimetrically. TDA formation was followed optically by the brownish complex in the
medium [19]. The absorption of the TDA-iron complex was measured at 398 nm [9]. Addi-
tionally, we determined absorption at 302 nm which is the main absorption maximum for
TDA (S3 File, S3 Fig).
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For growth curves and metabolome analysis, 500 mL Erlenmeyer flasks with 3 baffles were
used.
For determination of the oxygen uptake rate, the cultures were also grown in 500 mL baf-
fled Erlenmeyer flasks with 100 mL medium. On the bottom inside each flask was an optical
oxygen sensor spot (SP-PSt3-YAU-D7-YOP; PreSens, Regensburg, Germany) attached. The
incubator was equipped with an online oxygen monitoring device (Shake Flask Reader; Pre-
Sens, Regensburg, Germany). The measurement of the dissolved oxygen (DO) in the culture
medium is based on fluorescence quenching [20] and the amount of fluorescence signal
decrease is correlated to the oxygen concentration in the solution. Data acquisition and analy-
sis was carried out with Shake Flask Reader Software v2.0.0 (PreSens, Regensburg, Germany)
and the oxygen uptake rate (OUR) was automatically calculated. The specific OUR was calcu-
lated with the growth rate during the linear growth phase.
Medium exchange experiment
Medium exchange experiments were performed in 250 mL Erlenmeyer flasks with 3 baffles.
Cells were grown to ½ ODmax and harvested by centrifugation. The culture supernatants were
sterile filtered and the cells were resuspended in either their own or the culture supernatant of
another strain before the resulting growth rate was determined. For a detailed workflow
description of the medium exchange experiment see results and discussion.
Amino acid quantification and metabolome analysis
Amino acids were quantified in samples taken at half-maximal and maximal growth of 4 bio-
logical cultivations. Samples were prepared and analyzed by a 1260 Infinity HPLC system
equipped with a fluorescence detector (Agilent Technologies, Waldbronn, Germany) and a
Poroshell HPH-C18 separation column (4.6 x 100 mm, particle size 2.7 mm; Agilent Technol-
ogies) as described previously [21]. Samples for metabolome analysis were taken of 4 biological
cultivations at half-maximal growth and each cultivation was analyzed in triplicates. Cell lysis,
preparation and metabolome analysis was performed as described previously [18, 22] with
some minor modifications: ethanol was replaced by methanol and 500 μL of the polar phase
were dried prior to derivatization.
Results and discussion
Growth behavior of mutants with a missing or incomplete TDA
biosynthesis
Four transposon mutants (tdaA, tdaB, tdaC, tdaE), the plasmid-cured mutant (Δ262-kb) and
the corresponding wild-type P. inhibens DSM 17395 were cultivated with casamino acids as
Table 1. Strains used in this work.
Strain genetic modification Position of the transposon Reference
DSM 17395 wild-type strain – DSMZ1
Δ262-kb curation of the 262 kb plasmid in DSM 17395 – [8]
tdaA tdaA transposon mutant of DSM 17395 107502+ this work
tdaB tdaB transposon mutant of DSM 17395 106916- this work
tdaC tdaC transposon mutant of DSM 17395 105936+ this work
tdaE tdaE transposon mutant of DSM 17395 104157- this work
1 DSMZ = German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany
https://doi.org/10.1371/journal.pone.0177295.t001
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the carbon source. In absence of a functional TDA biosynthesis, the maximal biomass concen-
tration was reached after approximately 20 h of growth due to the depletion of any available
carbon source while the wild-type showed a drastically reduced growth rate, lower final bio-
mass yield and entered the stationary growth phase after 30 h despite a remaining high concen-
tration of amino acids (total amount 6.04 ± 1.44 mM, corresponding to 16% of the initial
concentration) in the medium (Fig 1, S1 Table). Overall the different transposon mutant strains
showed an approximately 11% lower biomass yield than the Δ262-kb mutant strain while the
growth rates during the linear growth phase remained similar. In contrast the biomass yield of
the wild-type was reduced by approximately 35% compared to the transposon mutants and by
approximately 41% compared to the Δ262-kb mutant strain. The difference in amino acid
depletion for plasmid-cured mutant and wild-type was already observed by Trautwein et al.
(2016) [8]. The lower growth yield for the wild-type was explained by its slow replication rate
or the metabolic burden for plasmid carriage and production of exopolysaccharides. However,
our growth experiment showed that the growth inhibition of the wild-type is directly connected
to the TDA biosynthesis as its biosynthesis is encoded by the 262 kb plasmid. The data suggest
that only a minor effect can be attributed to other metabolic pathways encoded by the 262 kb
plasmid or the metabolic costs of plasmid carriage.
Medium exchange between wild-type and TDA-free mutants
To exclude the possible costs of TDA biosynthesis itself as the source for the decrease of
growth yield, a selected transposon mutant (tdaE) and the plasmid-cured mutant (Δ262-kb)
Fig 1. Growth curves of P. inhibens DSM 17395 wild-type and tropodithietic acid (TDA)-free mutants
on casamino acids. Blue squares/line: wild-type, orange circles/line: plasmid-cured mutant Δ262-kb, black
triangles/line: tdaA transposon mutant, red triangles/line: tdaB transposon mutant, green triangles/line: tdaC
transposon mutant, ocher triangles/line: tdaE transposon mutant. Cell dry weight (CDW) was determined of
overall 7 biological replicates from 2 independent cultivations. Time points of biological replicates were
corrected for the lag phase to the replicate with the shortest lag phase. Due to the specific growth behavior,
growth curves were only fitted until CDWmax according to the Boltzmann model using OriginPro2015 software,
further time points were measured.
https://doi.org/10.1371/journal.pone.0177295.g001
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were applied in medium exchange experiments with the wild-type (Fig 2). We selected the
transposon mutant of the tdaE gene encoding an acyl-CoA dehydrogenase which catalyzes the
first step of the tda operon in the TDA biosynthesis [10] to avoid side effects of precursors on
the metabolism. The presence of TDA in the supernatant of the wild-type under the given
growth conditions was verified by measurement of absorption at 302 and 398 nm (S3 File and
S3 Fig). A growth inhibition was observed for both mutants after transferring the cells into the
culture supernatant of the wild-type. Furthermore, the wild-type showed an increased growth
rate when transferred to the TDA-free supernatant of the mutants. As a control experiment,
Fig 2. Medium exchange experiment between the wild-type and tropodithietic acid (TDA)-free mutants. TDA-free mutants and the wild-type
were simultaneously grown until about½ODmax. The cells of TDA-free mutants and wild-type were separated from their medium and resuspended in
the supernatant of the wild-type and TDA-free mutant, respectively. The reference cultures were resuspended in its own supernatant. Subsequently,
the cultivation was continued. The linear growth rates (g L-1 h-1) were determined by linear fit of the cell dry weight (CDW) values in the first hours after
the exchange procedure. Arrows indicate the medium (red: with TDA, grey: without TDA). The background shows the strain (red: TDA-producing
strain, grey: strain with missing or incomplete TDA biosynthesis).
https://doi.org/10.1371/journal.pone.0177295.g002
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we performed an exchange of the culture supernatant between the two TDA-free mutants to
check whether the process of changing the medium or any difference in the amino acid con-
centration has an influence on the growth rate. Growth rates after this medium exchange were
similar to the growth rates before the change (S1 Fig).
The growth inhibition caused by the culture supernatant of the wild-type showed that a
produced compound of the wild type is the cause for the inhibition effect. The control experi-
ment with an exchange between transposon and plasmid-cured mutant approved that the
growth inhibition is directly connected to TDA.
Constant oxygen uptake rates allow only lower growth rates in presence
of TDA
The resistance mechanism proposed by Wilson et al. (2016) [15] assumes that glutamate is
available in the medium and γ-aminobutanoic acid (GABA) would be excreted. However, glu-
tamate is one of the preferred amino acids and is rapidly consumed by P. inhibens [5]. In con-
trast to the proposed resistance mechanism of Wilson et al. (2016) [15], we could not detect
any accumulation of γ-aminobutanoic acid in the culture supernatant. P. inhibens shows only
a decreased growth rate pointing to a high energy demand. A partial destruction of the proton
gradient means that more respiratory activity is required to obtain the necessary ATP regener-
ated by ATP hydrolase. In previous studies, an almost 2-fold higher oxygen consumption per
cellular dry weight was observed for the wild-type compared to the plasmid-cured mutant in
processed-controlled bioreactors [8]. Thus, we measured the oxygen saturation in Erlenmeyer
flasks and determined the oxygen uptake rate (OUR) in relation to the biomass at different
time points of growth (Table 2, S2 Table, S2 Fig). All mutants showed a constant growth rate
until CDWmax while the wild-type strain showed a decreasing growth rate with proposed accu-
mulation of TDA in the culture supernatant, correlating with the brown color. In contrast, the
OUR remained comparable at approximately 1000 L h-1 g-1 for the wild-type and the mutants
until the transition phase. In the context of the mode of action of TDA [15], this indicates that
at constant oxygen uptake rates per cell dry weight, the presence of TDA leads to a slower
growth rate due to lower ATP yield without any decrease of respiratory activity.
Table 2. Oxygen uptake rates and growth rates.
strain Time point Relative growth rate [%] OUR/CDW [L g-1 h-1]
DSM 17395 ½ODmax 100 ± 6 1091 ± 61
ODmax 82 ± 12 1033 ± 63
~ ODmax 35 ± 17 893 ± 125
Δ262-kb ½ODmax 100 ± 1 999 ± 49
ODmax 114 ± 4 1030 ±13
~ ODmax 110 ± 8 859 ± 138
tdaE ½ODmax 100 ± 8 1075 ± 147
ODmax 115 ± 14 1072 ± 144
~ ODmax 111 ± 15 1038 ± 112
Shown are relative growth rates to the growth rate at½ODmax and oxygen uptake rate (OUR) based on the
cell dry weight (CDW) for the wild-type strain DSM 17395 and the mutant strains Δ262-kb and tdaE
determined for 3 biological replicates each. 3 time points were chosen for the comparison (½ODmax, ODmax
and shortly before reaching ODmax). For detailed information see experimental procedures, S2 Table and S2
Fig.
https://doi.org/10.1371/journal.pone.0177295.t002
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Metabolome analysis of wild-type and TDA-free mutant strains
As we could not detect a higher respiratory activity, we performed a metabolome analysis of
the wild-type and the two mutant strains (tdaE and Δ262-kb) to analyze possible differences
in their metabolism (Fig 3, S3 and S4 Tables). Only few changes in metabolites could be
observed for the tdaE mutant compared to the wild-type strain (Fig 3A) in cells at half-maxi-
mal biomass yield. N-acetyl-serine was only detectable in the wild-type strain and may be
involved in regulatory functions. Increased levels of valine and tyrosine in the wild-type in
comparison to the tdaE mutant may be attributed to the different amino acid utilization at
half-maximal growth as both amino acids were less or not used by the wild-type strain at this
stage of growth (S5 Table). From half-maximal growth on, isoleucine and leucine are less
consumed by the wild-type which may explain the observed increased intracellular levels at
half-maximal growth (S1 Table). 2-Isopropylmalate is directly linked to increased levels of
valine. These experiments show that the inhibition by TDA has only minor direct effects on
metabolic processes except slower biosynthesis rates. Furthermore, we compared the meta-
bolome of the tdaE transposon mutant with the plasmid-cured strain (Fig 3B). Again, we
detected differences in isoleucine, valine and its degradation product 3-aminoisobutanoate.
Other metabolites which are altered between the strains can be attributed to genes encoded
by the 262 kb plasmid involved into the proposed lysine degradation pathway via pipecolate
in P. inhibens [23]. One gene (locus tag: PGA1_262p02210) shows sequence similarity to the
pipecolate oxidase in Pseudomonas putida KT 2440 (40% identity, E-value 4E-97) [24]. Thus,
Fig 3. Comparison of logarithmized normalized peak areas of tropodithietic acid (TDA)-free mutants. TDA-free mutants and the wild-
type were simultaneously grown until about½ODmax. Shown are metabolites found in cell extracts after cultivation on casamino acids in
comparison of the tdaE mutant to the wild-type (A) and the Δ262-kb mutant (B). Values represent the average of four independent experiments.
Error bars represent the standard error between the four experiments.
https://doi.org/10.1371/journal.pone.0177295.g003
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concentrations of several metabolites of the different lysine degradation pathways are
altered: cadaverine, pipecolate, 5-aminopentanoate and 2-aminoadipate. The unidentified
compound D200302 shows the typical mass spectrum and retention index of a modified
sugar and can be attributed to alterations due to the absence of the exopolysaccharide
biosynthesis proteins encoded by a gene cluster on the 262 kb plasmid (locus tags:
PGA1_262p00050 to PGA1_262p00130) with sequence similarities to the succinoglycan
biosynthesis of Rhizobium meliloti 1021 [25] (S6 Table). Overall, none of the changes in the
metabolome can be directly attributed to the influence of TDA.
Conclusion
In this work we demonstrate that the presence of the antibacterial compound TDA in P. inhi-
bens DSM 17395 is associated with a dramatic impact on the growth of the bacterium. The
TDA-producing wild-type strain shows a reduced growth rate and—more importantly—a sig-
nificantly lower biomass yield at the same oxygen uptake rate as the mutants, we could not
observe any counteraction neither on metabolic level nor on the respiratory activity. Accord-
ingly, our data support the effect of TDA on the proton motive force proposed by Wilson et al.
(2016) [15]. Moreover, we show that TDA is the major reason for the observed growth restric-
tion by the 262 kb plasmid previously reported by Trautwein et al. (2016) [8]. Only a minor
part can be attributed to other genes encoded by the plasmid. As TDA biosynthesis genes
encoding plasmids can be found in all Phaeobacter species [6, 26, 27], TDA must provide a sig-
nificant advantage to P. inhibens in a competition for nutrients which compensates the high
energetic costs.
Supporting information
S1 Fig. Medium exchange experiment between the mutant strain Δ262-kb and tdaE (con-
trol experiment). Experiment was performed analog to the main experiment (Fig 2). Super-
natant of the plasmid-cured mutant was changed with the supernatant of the transposon
mutant. The growth rate was determined directly after the exchange procedure. For detailed
workflow see Fig 2 and experimental procedure. Grey bars: reference, white bars: medium
exchange.
(PDF)
S2 Fig. Measurement of oxygen uptake in erlenmeyer flasks with the shake flask reader.
Shown are the growth curves with corresponding dissolved oxygen saturation (DO) and oxy-
gen uptake rate (OUR) for the wild-type strain DSM 17395 and the mutant strains Δ262-kb
and tdaE. The growth curves were fitted until CDWmax according to the Boltzmann model
using OriginPro2015 software. For determination of growth rates at the chosen time points,
the fit was differentiated to get the slope at this point. For detailed information on the oxygen
uptake measurement see experimental procedures.
(PDF)
S3 Fig. Verification of TDA production. Shown are growth curves with corresponding
absorption at 302 nm (TDA) and 398 nm (iron-complexed TDA) for the wild-type strain
DSM 17395 and as controls for the mutant strains Δ262-kb and tdaE.
(PDF)
S1 File. Authenticity of transposon mutants.
(PDF)
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S2 File. TDA biosynthetic gene cluster and proposed biosynthesis pathway.
(PDF)
S3 File. Absorption spectrum of TDA, culture supernatants of the wild-type strain DSM
17395 and the mutant strains Δ262-kb and tdaE and of the casamino acids medium.
(PDF)
S1 Table. Amino acid consumption upon entering the stationary phase in the wild-type
strain DSM 17395 and the mutant strains Δ262-kb, tdaA, tdaB, tdaC and tdaE. Analyzed
were the concentrations of all amino acids present in casein hydrolysate (casamino acids) in
the stationary growth phase via HPLC-FLD (see Experimental Procedures). Shown are the
amino acids concentrations (mmol L-1) of each replicate and the calculated mean values with
corresponding deviation.
(XLSX)
S2 Table. Measurement of oxygen uptake in erlenmeyer flasks with the shake flask reader.
The table contains all chosen OD values with corresponding cell dry weight (CDW) values for
the wild-type strain DSM 17395 and the mutant strains Δ262-kb and tdaE. Furthermore, it
contains the corresponding dissolved oxygen saturation (DO) and oygen uptake rate (OUR)
data as well as the OUR based on CDW. For detailed information on the oxygen uptake mea-
surement see experimental procedures.
(XLSX)
S3 Table. Metabolome analysis of the wild-type strain DSM 17395 and mutant strains tdaE
and Δ262. Shown are the normalized peak areas of each replicate and the calculated mean val-
ues with corresponding standard error of all identified metabolites detected at least in one of
the strains. nd: not detectable.
(XLSX)
S4 Table. Metabolome analysis of the mutant strains tdaE and Δ262 compared to the wild-
type strain DSM 17395. Shown are all identified metabolites detected at least in one of the
strains. Fold changes are calculated between the indicated strains (strain A/strain B in the col-
umn heading) including corresponding standard error. nd: metabolite not detectable in strain
A; +: metabolite detectable in strain A but not in strain B; -: metabolite neither detectable in
strain A nor in strain B.
(XLSX)
S5 Table. Amino acid consumption at½ODmax in the wild-type strain DSM 17395 and the
mutant strains Δ262-kb and tdaE. Analyzed were the concentrations of all amino acids pres-
ent in casein hydrolysate (casamino acids) at ½ ODmax via HPLC-FLD (see Experimental Pro-
cedures). Shown are the amino acids concentrations (mmol L-1) of each replicate and the
calculated mean values with corresponding deviation.
(XLSX)
S6 Table. Putative exopolysaccharide biosynthesis gene cluster. Shown are blastp hits
against the genome of Rhizobium meliloti 1021 with corresponding E-values and identities.
Furthermore, the sequences were analyzed with InterPro to predict domains.
(XLSX)
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